Myopic choroidal neovascularization

Ophthalmology

Volumn 118, Issue 12, 2011, Pages 2521-2523

  Ruiz Moreno, Jose M ^a   López Gálvez, María I ^a   Donate, Juan ^a   Gomez Ulla, Francisco ^a   García Arumí, José ^a   García Layana, Alfredo ^a   Sellés, Inmaculada ^a   Reche, Juan ^a   Montero, Javier A ^a   Pazos, Belen ^a   Zapata, Miguel A ^a   Pastor, José C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

ADULT; AGED; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; EYE EXAMINATION; FEMALE; FOLLOW UP; HIGH MYOPIA; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA FOVEA; RETINA MACULA HEMORRHAGE; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY; VISUAL IMPAIRMENT;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; CHOROIDAL NEOVASCULARIZATION; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FOVEA CENTRALIS; HUMANS; INTRAVITREAL INJECTIONS; MIDDLE AGED; MYOPIA, DEGENERATIVE; PHOTOCHEMOTHERAPY; PROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 82755195085     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2011.07.029     Document Type: Letter

References (5)

1. Verteporfin in Photodynamic Therapy Study Group Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin 1-year results of a randomized clinical trialVIP report no. 1 Ophthalmology 108 2001 841 852
2. J.P. Tong, W.M. Chan, and D.T. Liu Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization Am J Ophthalmol 141 2006 456 462 (Pubitemid 43265948)
3. K. Hayashi, K. Ohno-Matsui, and S. Teramukai Comparison of visual outcome and regression pattern of myopic choroidal neovascularization after intravitreal bevacizumab or after photodynamic therapy Am J Ophthalmol 148 2009 396 408
4. J.M. Ruiz-Moreno, J.A. Montero, and L. Arias Twelve-month outcome after one intravitreal injection of bevacizumab to treat myopic choroidal neovascularization Retina 30 2010 1609 1615
5. J.M. Ruiz-Moreno, and J.A. Montero Intravitreal bevacizumab to treat myopic choroidal neovascularization: 2-year outcome Graefes Arch Clin Exp Ophthalmol 248 2010 937 941